Results 1 to 10 of about 44,365 (244)
For Preparedness as Transformation
Sociologica, Vol. 15 No. 3 (2021)
Bifulco, L, Centemeri, L, Mozzana, C
openaire +5 more sources
ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets
Vaccines against SARS-CoV-2 are likely to be critical in the management of the ongoing pandemic. A number of candidates are in Phase III human clinical trials, including ChAdOx1 nCoV-19 (AZD1222), a replication-deficient chimpanzee adenovirus-vectored ...
Glenn A. Marsh+43 more
doaj +1 more source
Chikungunya is an arboviral disease caused by the chikungunya virus (CHIKV) afflicting tropical and sub-tropical countries worldwide. It has been identified as a priority pathogen by the Coalition for Epidemics Preparedness Innovations (CEPI) and as an ...
Neil Cherian+8 more
doaj +1 more source
Framing the future of the COVID-19 response operations in 2022 in the WHO African region
Background With the evolving epidemiological parameters of COVID-19 in Africa, the response actions and lessons learnt during the pandemic’s past two years, SARS-COV 2 will certainly continue to circulate in African countries in 2022 and beyond.
Thierno Balde+12 more
doaj +1 more source
Availability and use of Standards in vaccine development
Reference materials are critical in assay development for calibrating and assessing their suitability. The devasting nature of the COVID-19 pandemic and subsequent proliferation of vaccine platforms and technologies has meant that there is even a greater
Michael Selorm Avumegah+12 more
doaj +1 more source
COVID-19 case management strategies: what are the options for Africa?
The ongoing coronavirus disease 2019 (COVID-19) pandemic has put a strain on health systems globally. Although Africa is the least affected region to date, it has the weakest health systems and an exponential rise in cases as has been observed in other ...
Joy Luba Lomole Waya+4 more
doaj +1 more source